Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lypro Biosciences
AddedFeb 18, 2024
UpdatedJun 18, 2026
Lypro Biosciences

Lypro Biosciences

US-based Lypro Biosciences innovatively tackles the insolubility issues of hydrophobic drugs.

HQ
Berkeley, CA, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

Lypro Biosciences is a therapeutic development company based in Berkeley, United States. The company's core mission is to enhance the solubility and bioavailability of hydrophobic drugs and other therapeutic compounds through its proprietary drug delivery nanotechnology. Lypro's innovative platform, inspired by the body's natural mechanisms for transporting insoluble compounds, utilizes self-assembling, targetable nanometer-scale bioparticles called "NanoDisk" to facilitate targeted drug delivery.

Lypro Biosciences has made significant strides in addressing the challenges associated with hydrophobic drugs, potentially revolutionizing the way these compounds are delivered and utilized in medical treatments. The company's technology not only improves drug solubility but also ensures precise targeting to specific receptors, enhancing therapeutic efficacy and reducing side effects. This breakthrough has positioned Lypro as a key player in the field of drug delivery systems, contributing to advancements in pharmaceutical sciences and patient care.

Lypro Biosciences - Similar Companies

Nanomedex Pharmaceuticals logo

Nanomedex Pharmaceuticals

Nanocopoeia logo

Nanocopoeia

nanocopoeia.com

Leonardo Biosystems logo

Leonardo Biosystems

Nano PharmaSolutions logo

Nano PharmaSolutions

Lindy Biosciences logo

Lindy Biosciences

lindybio.com

LayerBio logo

LayerBio

layerbio.com

Extend Biosciences logo

Extend Biosciences

extendbio.com

Advanced NanoTherapies logo

Advanced NanoTherapies

Optimeos Life Sciences logo

Optimeos Life Sciences

optimeos.com

Ascendia Pharmaceuticals logo

Ascendia Pharmaceuticals

ascendiapharma.com

Recon Therapeutics logo

Recon Therapeutics

InSitu Biologics logo

InSitu Biologics

NantBio logo

NantBio

Souvie Biodelivery logo

Souvie Biodelivery

Asalyxa Bio logo

Asalyxa Bio

Lypro Biosciences - Quick Facts

Who are Lypro Biosciences' competitors?

Companies similar to Lypro Biosciences include Nanomedex Pharmaceuticals, Nanocopoeia, Leonardo Biosystems and Nano PharmaSolutions.

When was Lypro Biosciences founded?

Lypro Biosciences was founded in 2004.

Where is Lypro Biosciences' headquarters located?

Lypro Biosciences' headquarters is located in Berkeley, CA, US.

When was Lypro Biosciences' last funding round?

Lypro Biosciences' most recent funding round was for $177.9k (USD) in September 2010.

How much has Lypro Biosciences raised to-date?

As of Sep 6, 2010, Lypro Biosciences has raised a total of $177.9k (USD).

How many employees does Lypro Biosciences have?

Lypro Biosciences has 6 employees as of Feb 5, 2024.

Lypro Biosciences - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
  • Nanotechnology
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Delivery
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified